机译:羟吡格吡酰型脂质化脂质体及其对抗PEG IgM诱导的影响及其加速脂质化脂质体的促进
Tokushima Univ Dept Pharmacokinet &
Biopharmaceut Inst Biomed Sci 1-78-1 Sho Machi Tokushima;
Tokushima Univ Dept Pharmacokinet &
Biopharmaceut Inst Biomed Sci 1-78-1 Sho Machi Tokushima;
Tokushima Univ Dept Pharmacokinet &
Biopharmaceut Inst Biomed Sci 1-78-1 Sho Machi Tokushima;
Tokushima Univ Dept Pharmacokinet &
Biopharmaceut Inst Biomed Sci 1-78-1 Sho Machi Tokushima;
Tokushima Univ Dept Pharmacokinet &
Biopharmaceut Inst Biomed Sci 1-78-1 Sho Machi Tokushima;
Tokushima Univ Dept Pharmacokinet &
Biopharmaceut Inst Biomed Sci 1-78-1 Sho Machi Tokushima;
Tokushima Univ Dept Pharmacokinet &
Biopharmaceut Inst Biomed Sci 1-78-1 Sho Machi Tokushima;
Tokushima Univ Dept Pharmacokinet &
Biopharmaceut Inst Biomed Sci 1-78-1 Sho Machi Tokushima;
Tokushima Univ Dept Pharmacokinet &
Biopharmaceut Inst Biomed Sci 1-78-1 Sho Machi Tokushima;
ABC phenomenon; anti-PEG IgM; Complement activation; Liposome; PEGylation; Terminal functional group;
机译:羟吡格吡酰型脂质化脂质体及其对抗PEG IgM诱导的影响及其加速脂质化脂质体的促进
机译:先前脂质体注射后PEG化脂质体的血液清除加速:脂质剂量和PEG表面密度以及首剂脂质体链长的影响
机译:肝瓣蜂鸣细胞间接有助于抗-peg IgM生产在加速血液清除(ABC)现象中对乙二醇化脂质体的现象:ABC现象中未解释的机制的出现
机译:首次注射聚乙二醇化脂质体后分泌的IgM参与了ABC现象的诱导
机译:通过聚乙二醇化脂质体递送的抗癌药的临床药代动力学和药效学。
机译:小鼠和大鼠对PEG化脂质体的抗PEG IgM反应
机译:抗聚乙二醇(PEG)免疫球蛋白M(IgM)浓度与小鼠聚乙二醇化脂质体的加速血液清除(ABC)现象的关系